[Effects of 18β-sodium glycyrrhetinic acid on TNF-α expression in rats with allergic rhinitis]

Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019 Mar;33(3):262-266. doi: 10.13201/j.issn.1001-1781.2019.03.019.
[Article in Chinese]

Abstract

Objective:To observe the effect of 18β-sodium glycyrrhetinic acid(18β-SGA) on the expression of TNF-α in nasal mucosa of rats with allergic rhinitis(AR), and explore the intervention mechanism of 18β-SGA on AR. Method:One hundred and six SPF-level Wistar rats were randomly divided into control group, AR group, budesonide group, 18β-SGA low dose group and high dose group. After the AR rat model was constructed by ovalbumin, the rats were given drug intervention and sacrificed after 2 and 4 weeks of intervention. The nasal mucosa of the rats was taken for immunohistochemical staining, RT-qPCR and Western-blotting to localize and quantify the expression of TNF-α. Result:By immunohistochemistry, Western-blotting and RT-PCR, TNF-α was mainly found in the columnar epithelium, vascular endothelium, glandular and some inflammatory cytoplasm of nasal mucosa. And the expression of TNF-α in the nasal mucosa of AR rats was significantly increased than the normal group at the protein and mRNA levels (P<0.01). After intervention with different doses of 18β-SGA, the expression of TNF-α was significantly decreased (P<0.01), especially after 4 weeks of 18β-SGA low dose group(P<0.01). Conclusion:Different doses of 18β-SGA have therapeutic effects on AR, and its mechanism of action may be related to the inhibition of TNF-α expression.

目的:观察18β-甘草次酸钠(18β-SGA)对变应性鼻炎(AR)大鼠鼻黏膜肿瘤坏死因子-α(TNF-α)表达的影响,探讨18β-SGA对AR的干预机制。方法:106只SPF级Wistar大鼠随机分为空白对照组、AR组、布地奈德组、18β-SGA低剂量组和18β-SGA高剂量组。经卵清蛋白构建AR大鼠模型后给予药物干预,各组大鼠分别在干预2周和4周后处死,取大鼠鼻黏膜行免疫组织化学染色、RT-PCR和免疫蛋白印迹定位、定量大鼠鼻黏膜中TNF-α表达。结果:经免疫组织化学、免疫印迹及RT-PCR发现,与空白对照组相比,AR组大鼠鼻黏膜中TNF-α高表达于鼻黏膜纤毛柱状上皮、血管内皮、腺体及部分炎症细胞胞质中(P<0.01)。经不同剂量的18β-SGA干预后,TNF-α表达量明显下降(P<0.01),尤以18β-SGA低剂量组干预4周后效果最明显(P<0.01)。结论:不同剂量的18β-SGA对AR有治疗作用,且其发挥作用的机制与抑制TNF-α的高表达有关。.

Keywords: rhinitis, allergic; 18β-sodium glycyrrhetinic acid; tumor necrosisi factor-α.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents* / pharmacology
  • Disease Models, Animal
  • Glycyrrhetinic Acid* / pharmacology
  • Nasal Mucosa
  • Random Allocation
  • Rats
  • Rats, Wistar
  • Rhinitis, Allergic* / drug therapy
  • Rhinitis, Allergic* / metabolism
  • Sodium
  • Tumor Necrosis Factor-alpha* / drug effects
  • Tumor Necrosis Factor-alpha* / metabolism

Substances

  • Anti-Inflammatory Agents
  • Tumor Necrosis Factor-alpha
  • Sodium
  • Glycyrrhetinic Acid